Surface screening, molecular modeling and in vitro studies on the interactions of aflatoxin M1 and human enzymes acetyl- and butyrylcholinesterase
Language English Country Ireland Media print-electronic
Document type Journal Article
PubMed
31100275
DOI
10.1016/j.cbi.2019.05.022
PII: S0009-2797(19)30335-7
Knihovny.cz E-resources
- Keywords
- Acetylcholinesterase, Aflatoxin M1, Butyrylcholinesterase, Molecular modeling, Surface screening,
- MeSH
- Acetylcholinesterase chemistry metabolism MeSH
- Aflatoxin B1 chemistry metabolism MeSH
- Aflatoxin M1 chemistry metabolism MeSH
- Aspergillus metabolism MeSH
- Butyrylcholinesterase chemistry metabolism MeSH
- Catalytic Domain MeSH
- Humans MeSH
- Surface Properties MeSH
- Molecular Dynamics Simulation MeSH
- Thermodynamics MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Acetylcholinesterase MeSH
- Aflatoxin B1 MeSH
- Aflatoxin M1 MeSH
- Butyrylcholinesterase MeSH
Aflatoxin M1 (AFM1) is a mycotoxin produced by Aspergillus fungi and found in contaminated milk, breastfeed and dairy products, being highly toxic and carcinogenic to humans and other mammalian species. It is also produced in the human body as a metabolite of aflatoxin B1 (AFB1), one of the most toxic natural products known. Previous studies have shown that AFM1 is a potential inhibitor of the enzyme acetylcholinesterase (AChE), and therefore, a potential neurotoxic agent. In this work, surface screening (SS) and molecular dynamics (MD) simulation on human acetylcholinesterase AChE (HssAChE) were performed to corroborate literature data regarding preferential binding sites and type of inhibition. Also, an inedited theoretical study on the interactions of AFM1 with human butyrylcholinesterase (HssBChE) was performed. In vitro inhibition tests on both enzymes were done to support theoretical results. MD simulations suggested the catalytic anionic site of HssAChE as the preferential binding site for AFM1 and also that this metabolite is not a good inhibitor of HssBChE, corroborating previous studies. In vitro assays also corroborated molecular modeling studies by showing that AFM1 did not inhibit BChE and was able to inhibit AChE, although not as much as AFB1.
References provided by Crossref.org
